Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

eMI Aesthetics vs GOAL.MD

By GLP-1 ScorecardUpdated

eMI Aesthetics
Site position #118

Higher grade

GOAL.MD
Site position #159

Lower grade

Score comparison

eMI Aesthetics has the higher recorded score — 70.3/100 to 68.6/100, but only just.

eMI Aesthetics grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. eMI Aesthetics is a US direct-to-consumer telehealth brand offering doctor-guided GLP-1 weight loss programs to eligible patients in all 50 states. GOAL.MD is close behind and may still be the better fit — see the factor split below.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueeMI Aesthetics +8
73
65
Dose & formulationGOAL.MD +2
84
86
Clinical oversighteMI Aesthetics +2
70
68
Labs & monitoringGOAL.MD +2
51
53
FulfillmentEven
77
77
Contract termsEven
55
55
eMI Aesthetics · top barGOAL.MD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetriceMI AestheticsGOAL.MD
WeighScore70.3/10068.6/100
GradeCC
Site position#118#159
Semaglutide$179/mo (all doses, compounded)$179/mo (month-to-month, compounded)
TirzepatideNot disclosed$249/mo (flat-dose monthly, compounded)
CoverageAll 50 statesAdvertises all 50 states; clinical and pharmacy eligibility apply
Brand-name accessYesYes
Oral / sublingualYesYes
eMI Aesthetics

Site position #118 · C

Strengths

  • Available to eligible patients in all 50 states
  • Offers both semaglutide and tirzepatide, plus an oral semaglutide option
  • Intake and provider visits run through OpenLoop Health, an established telehealth network

What to consider

  • Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
  • No fill pharmacy or named medical director is publicly listed
  • Support appears limited to email, with no phone number or hours published
GOAL.MD

Site position #159 · C

Strengths

  • Compounded reorders require permission before charging
  • Advertised injection price stays the same across prescribed doses
  • Nutrition support and expedited shipping included in compounded plans
  • Advertises brand-name oral Wegovy access; medication costs extra

What to consider

  • Compounded orders become non-refundable when payment is processed
  • Lowest monthly equivalents require a twelve-month upfront payment
  • Brand-access page gives conflicting automatic-billing statements
  • Confirm the assigned dispensing pharmacy and its credentials
  • GOAL identifies a physician with historical discipline; Missouri ended restrictions in 2019 and records no current discipline at the October 2026 check

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard